Henning Stehr

9.3k total citations · 1 hit paper
71 papers, 2.5k citations indexed

About

Henning Stehr is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Henning Stehr has authored 71 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cancer Research, 25 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Henning Stehr's work include Cancer Genomics and Diagnostics (34 papers), Lung Cancer Treatments and Mutations (18 papers) and Lymphoma Diagnosis and Treatment (13 papers). Henning Stehr is often cited by papers focused on Cancer Genomics and Diagnostics (34 papers), Lung Cancer Treatments and Mutations (18 papers) and Lymphoma Diagnosis and Treatment (13 papers). Henning Stehr collaborates with scholars based in United States, Germany and United Kingdom. Henning Stehr's co-authors include Maximilian Diehn, Ash A. Alizadeh, Chih Long Liu, Aaron M. Newman, Scott V. Bratman, Heather A. Wakelee, Joel W. Neal, Li Zhou, Billy W. Loo and Robert B. West and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Henning Stehr

65 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrated digital error suppression for improved detection of circulating tumor DNA

2016 716 citations Aaron M. Newman, Alexander F. Lovejoy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henning Stehr United States	21	1.2k	1.2k	854	780	537	71	2.5k
Marco Gerlinger United Kingdom	22	1.2k 1.0×	1.1k 0.9×	955 1.1×	647 0.8×	290 0.5×	62	2.4k
Leticia De Mattos‐Arruda Spain	26	1.4k 1.2×	947 0.8×	1.3k 1.5×	735 0.9×	425 0.8×	54	2.7k
Richard D. Baird United Kingdom	22	1.7k 1.4×	1.7k 1.5×	1.4k 1.6×	1.0k 1.3×	526 1.0×	87	3.5k
Simon Pacey United Kingdom	20	1.7k 1.5×	2.2k 1.9×	1.3k 1.5×	1.1k 1.4×	448 0.8×	69	3.9k
Maria Schwaederlé United States	28	1.7k 1.4×	1.0k 0.9×	1.5k 1.8×	1.1k 1.4×	611 1.1×	43	3.2k
Christine Parkinson United Kingdom	14	2.4k 2.0×	1.2k 1.0×	1.4k 1.6×	1.3k 1.7×	623 1.2×	29	3.3k
Jens K. Habermann Germany	26	870 0.7×	1.2k 1.1×	1.0k 1.2×	307 0.4×	553 1.0×	91	2.6k
Iris Simón United States	29	708 0.6×	1.6k 1.4×	1.5k 1.7×	374 0.5×	778 1.4×	61	3.4k
Yinghui Guan China	22	1.1k 0.9×	1.5k 1.3×	876 1.0×	490 0.6×	200 0.4×	54	2.6k
Nicolas Stransky United States	17	837 0.7×	2.1k 1.8×	832 1.0×	720 0.9×	315 0.6×	27	3.2k

Countries citing papers authored by Henning Stehr

Since Specialization

Citations

This map shows the geographic impact of Henning Stehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Stehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Stehr more than expected).

Fields of papers citing papers by Henning Stehr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henning Stehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Stehr. The network helps show where Henning Stehr may publish in the future.

Co-authorship network of co-authors of Henning Stehr

This figure shows the co-authorship network connecting the top 25 collaborators of Henning Stehr. A scholar is included among the top collaborators of Henning Stehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Stehr. Henning Stehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khanna, Vishesh, Alexandria Jensen, Henning Stehr, et al.. (2025). Molecular taxonomy of MDS/CMML patients influences responses to hypomethylating agents and clinical outcomes. Leukemia Research. 156. 107736–107736. 1 indexed citations

Fernandez‐Pol, Sebastian, Henning Stehr, Carlos J. Suarez, et al.. (2025). MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis. npj Precision Oncology. 9(1). 34–34. 2 indexed citations

Khanna, Vishesh, Sebastian Fernandez‐Pol, Henning Stehr, et al.. (2024). MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis. 1 indexed citations

Khanna, Vishesh, Rong Lü, Jyoti Kumar, et al.. (2023). The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms. Leukemia Research. 136. 107433–107433. 5 indexed citations

Tung, Jack K., Michael S. Khodadoust, Youn H. Kim, et al.. (2023). Minimal/Measurable Residual Disease Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor. Journal of Molecular Diagnostics. 25(6). 331–341.

Schroers‐Martin, Joseph G., Joanne Soo, Florian Scherer, et al.. (2023). Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors. Cancer Discovery. 13(6). 1310–1323. 23 indexed citations

Wu, Julie, Eunji Choi, Nathaniel J. Myall, et al.. (2023). Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer. JAMA Network Open. 6(9). e2335813–e2335813. 6 indexed citations

Wu, Julie, Victoria Y. Ding, Sophia J. Luo, et al.. (2022). Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology. 6(6). e2200220–e2200220. 4 indexed citations

Jeong, Youngtae, Jessica A. Hellyer, Henning Stehr, et al.. (2019). Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(1). 274–281. 80 indexed citations

10.

Yang, Soo‐Ryum, Kelly L. Mooney, Carol D. Jones, et al.. (2019). Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology. Cancer Cytopathology. 128(1). 43–56. 22 indexed citations

11.

Rieger, Kerri E., et al.. (2019). 1008 Personalized treatment of cutaneous T-cell lymphoma through application of a targeted next generation sequencing panel. Journal of Investigative Dermatology. 139(5). S174–S174. 1 indexed citations

12.

Dudley, Jonathan C., Joseph G. Schroers‐Martin, Daniel Lazzareschi, et al.. (2018). Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA. Cancer Discovery. 9(4). 500–509. 151 indexed citations

13.

Schroers‐Martin, Joseph G., Florian Scherer, Joanne Soo, et al.. (2017). Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis. Blood. 130. 308–308. 1 indexed citations

14.

Soo, Joanne, Florian Scherer, David M. Kurtz, et al.. (2017). Reproducibility of m7-FLIPI Risk Scores in Follicular Lymphoma Using Tumor Biopsies and Blood Specimens. Blood. 130. 1466. 1 indexed citations

15.

Chuang, Jody C., Henning Stehr, Ying Liang, et al.. (2017). ERBB2 -Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies. Journal of Thoracic Oncology. 12(5). 833–842. 60 indexed citations

16.

Yang, Soo‐Ryum, Chieh‐Yu Lin, Henning Stehr, et al.. (2017). Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma. Journal of Molecular Diagnostics. 20(2). 184–194. 31 indexed citations

17.

Jeong, Youngtae, Ngoc T. Hoang, Alexander F. Lovejoy, et al.. (2016). Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. 7(1). 86–101. 243 indexed citations

18.

Chaudhuri, Aadel A., Alex Lovejoy, Jacob J. Chabon, et al.. (2016). CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). S41–S42. 3 indexed citations

19.

Stehr, Henning, José M. Duarte, Michael Lappé, Jong Bhak, & Dan Bolser. (2010). PDBWiki: added value through community annotation of the Protein Data Bank. Database. 2010(0). baq009–baq009. 21 indexed citations

20.

Duarte, José M., et al.. (2010). Optimal contact definition for reconstruction of Contact Maps. BMC Bioinformatics. 11(1). 283–283. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact